Ledger.Open graph →

SEC Form D · filed December 11, 2014

Cara Therapeutics, Inc

Offering

$100K

Sold

$100K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SHELTON, CT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Josef Schoell · Shelton, CTExec Derek Chalmers · Shelton, CTExec · Director Martin Vogelbaum · Shelton, CTDirector Frederique Menzaghi · Shelton, CTExec Darrin R. Witt · Charlotte, NCExec Jeffrey L. Ives · Shelton, CTDirector Joseph W. Stauffer · Shelton, CTExec Michael E. Lewis · Shelton, CTExec Dean Slagel · Paris, I0Director Harrison Bains · Shelton, CTDirector Michael R. Gardner · Charlotte, NCExec · Director John M. Carr · Charlotte, NCExec · Director Thomas C. Calame · Charlotte, NCExec Jeffrey L. Ives · Shelton, CTDirector Joseph W. Stauffer · Shelton, CTExec Michael E. Lewis · Shelton, CTExec Martin Vogelbaum · Lexington, MADirector Dean Slagel · Shelton, CTDirector Harrison Bains · Shelton, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗